Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01493362 · ClinicalTrials.gov registry record

Imaging the Dopamine Systems in Bulimia Nervosa

A clinical trial of Eating Disorders, sponsored by New York State Psychiatric Institute.

Completed
Registry status
33
Enrollment target
1
Study location

NCT01493362 is a study of Eating Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 33 participants, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01493362, a study of Eating Disorders, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

This study will use positron emission tomography imaging to investigate the dopamine systems in people with bulimia nervosa.

Conditions Studied

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2008-01
Est. Completion 2013-12

What the Registry Record Tells You About NCT01493362

The ClinicalTrials.gov registry entry for NCT01493362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (90% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT01493362 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01493362 about?

NCT01493362 is a clinical study titled "Imaging the Dopamine Systems in Bulimia Nervosa". This study will use positron emission tomography imaging to investigate the dopamine systems in people with bulimia nervosa.

What is the current status of trial NCT01493362?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2008-01. Estimated completion is 2013-12.

What conditions does trial NCT01493362 study?

This clinical trial studies the following conditions: Eating Disorders.

Who is sponsoring clinical trial NCT01493362?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01493362 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.